184 related articles for article (PubMed ID: 20832672)
1. When Is a "BED" not a "BED"?-When it is an EQD2: In regard to Buyyounouski et al. (Int J Radiat Oncol Biol Phys 2010;76:1297-1304).
Fowler JF; Dale RG
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):640-1. PubMed ID: 20832672
[No Abstract] [Full Text] [Related]
2. Cyberknife and prostate cancer. In regard to King et al. (Int J Radiat Oncol Biol Phys 2009;73:1043-1048).
Vikram B
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):632. PubMed ID: 19735890
[No Abstract] [Full Text] [Related]
3. Linear quadratic modeling of increased late normal-tissue effects in special clinical situations: in regard to Jones et al. (Int J Radiat Oncol Biol Phys 2006;64:948-953).
Mandal A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):631; author reply 631-2. PubMed ID: 16966009
[No Abstract] [Full Text] [Related]
4. Reporting of true spinal cord dose is encouraged for stereotactic body radiation therapy for spinal tumors. In regard to Sahgal et al. (Int J Radiat Oncol Biol Phys 2010;77:548-553).
Lo SS; Wang JZ; Radawski JD; Mayr NA
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):314; author reply 314. PubMed ID: 20708487
[No Abstract] [Full Text] [Related]
5. Balancing on a knife's edge: evidence-based medicine and the marketing of health technology. In regard to Bentzen et al. (Int J Radiat Oncol Biol Phys 2008;72:12-14).
Fuller DB
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):637-8. PubMed ID: 19147029
[No Abstract] [Full Text] [Related]
6. Radiobiological parameters suitable for modeling individual outcomes cannot be obtained by analyzing heterogeneous population data with homogeneous tumor control model: in regard to D'Souza et al. (Int J Radiat Oncol Biol Phys 2004;58:1540-1548).
Carlone M; Wilkins D; Raaphorst GP
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):298-9. PubMed ID: 15850946
[No Abstract] [Full Text] [Related]
7. Toward a unified survival curve: in regard to Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852) and Krueger et al. (Int J Radiat Oncol Biol Phys 2007;69:1262-1271).
Kavanagh BD; Newman F
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):958-9. PubMed ID: 18514788
[No Abstract] [Full Text] [Related]
8. Intraoperative radiation therapy after radical prostatectomy: in regard to Saracino et Al. (Int j radiat oncol biol phys, in press).
Jereczek-Fossa BA; Orecchia R
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):305-6; author reply 306. PubMed ID: 18722291
[No Abstract] [Full Text] [Related]
9. Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
Garces YI; Miller RC
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1636; author reply 1636-7. PubMed ID: 15050346
[No Abstract] [Full Text] [Related]
10. Brachytherapy doses for prostate cancer customized to risk factors: is it more important "how much" or "where"? In regard to Stone et al. (Int J Radiat Oncol Biol Phys 2007;69:1472-1477).
Oton CA; Oton F
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):962; author reply 962-3. PubMed ID: 18514795
[No Abstract] [Full Text] [Related]
11. Determination of TGF-beta1 plasma levels: In regard to Anscher et al. (Int J Radiat Oncol Biol Phys 2003;56: 988-995) and de Jaeger et al (Int J Radiat Oncol Biol Phys 2004;58: 1378-1387).
Barthelemy-Brichant N
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1339; author reply 1339-40. PubMed ID: 15519811
[No Abstract] [Full Text] [Related]
12. In regard to Vordermark et al. (Int J Radiat Oncol Biol Phys 2004;58:1242-1250).
Koch CJ
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):1003-4; author reply 1004-5. PubMed ID: 15465220
[No Abstract] [Full Text] [Related]
13. In regard to Sperduto et al. (Int j radiat oncol biol phys 2008;70:510-514).
Weltman E; Brandt RA
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1292; author reply 1292-3. PubMed ID: 18313534
[No Abstract] [Full Text] [Related]
14. Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses: in regard to Milano et al. (Int J Radiat Oncol Biol Phys 2009;73:832-837).
Christodouleas JP; Marks LB
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1628; author reply 1628-9. PubMed ID: 19616752
[No Abstract] [Full Text] [Related]
15. In regard to Kased N et al. (Int j radiat oncol biol phys 2009;75:1132-1140).
Weltman E; Brandt RA
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):316; author reply 317. PubMed ID: 20394860
[No Abstract] [Full Text] [Related]
16. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
Yaeger TE
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
[No Abstract] [Full Text] [Related]
17. Radiotherapy in pleural malignant mesothelioma: why not! In regard to Scorsetti et al. (Int J Radiat Oncol Biol Phys 2010;77:942-949); Krayenbuehl et al. (Int J Radiat Oncol Biol Phys 2010;78:628-634).
Russi EG; Numico G; Ricardi U
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1279; author reply 1279-80. PubMed ID: 21353165
[No Abstract] [Full Text] [Related]
18. In regard to Arvold et al. (Int J Radiat Oncol Biol Phys 2005;62:207-212).
Moeller BJ; Dewhirst MW
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):970-1; author reply 971. PubMed ID: 16199328
[No Abstract] [Full Text] [Related]
19. In regard to Hoppe et al. (Int J Radiat Oncol Biol Phys 2008;72:1283-1286).
Lo SS; Fakiris AJ; Wang JZ; Mayr NA
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):977; author reply 978. PubMed ID: 19480981
[No Abstract] [Full Text] [Related]
20. Androgen Deprivation (AD) among low-risk and intermediate-risk prostate cancer patients: in regard to Ciezki et al. (Int J Radiat Oncol Biol Phys 2004;60:1347-1350).
Oton CA
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):291-2; author reply 292. PubMed ID: 15850937
[No Abstract] [Full Text] [Related]
[Next] [New Search]
